PROVIDER PROFILE · NPI 1750600656

Avnee ShahM.D.

DermatologyWest Orange, NJI

MEDICARE UTILIZATION · PART B · 2024

Total beneficiaries

729

Unique beneficiaries

—

Total services

1,122

Distinct HCPCS

Medicare payment

$59K

Peer benchmark

Total Medicare services vs. 360 Dermatology providers in NJ — bottom quintile (cohort median 2,586).

PRESCRIBING · PART D · 2024

Total Rx claims

273

Beneficiaries

—

Total drug cost

$251K

Distinct drugs

Brand share

12.8%

Top prescribed drugs

Ketoconazole54 claims

Triamcinolone Acetonide47 claims

Hydrocortisone38 claims

Clobetasol Propionate28 claims

Ixekizumab24 claims

QUALITY · MIPS · 2024

Final MIPS score

100.0

Quality

24.7

Cost

82.7

Improvement activities

40.0

Promoting interop.

100.0

Payment adjustment

1.05%

Group

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

Total received

$2K

Payment records

117

By payment type

Food and Beverage$2K

Education$15

REFERRAL NETWORK

Where Avnee Shah's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 6 inbound referrers · 0 outbound destinations.

Receives referrals from

Inbound — who sends patients here

Physician	Patients	Visits
SANDOVAL, MARINA	101	139
Laboratory Corporation Of America Holdings Clinical Laboratory · Raritan, NJ	73	124
HMH HOSPITALS CORPORATION	37	49
Bioreference Health, Llc Clinical Laboratory · Elmwood Park, NJ	27	53
Joseph Deluca Ophthalmology · Lyndhurst, NJ	13	27
Yijun Guo Pathology · Wilkes-Barre, PA	12	12

Refers patients to

Outbound — where patients go next

No outbound pairs above the suppression threshold.

Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history